Literature DB >> 30509442

Nonradiographic axial spondyloarthritis.

Megan M Lockwood1, Lianne S Gensler2.   

Abstract

Non-radiographic axial spondyloarthritis (nr-axSpA) is a complex disease process that is part of the spectrum of axial spondyloarthritis (axSpA). This article reviews the current state of the literature as the understanding of this disease spectrum expands. The conceptual history and terminology, genetics, and epidemiology are reviewed. The clinical manifestations, diagnostic approach, and measures of disease activity are examined. Finally the current treatment modalities and recommendations and the research agenda for nr-axSpA are reviewed. With the advent of new criteria, the disease spectrum can be studied in a systematic manner. These data have enriched our knowledge that reflects an earlier or milder form of disease on a spectrum same as that of ankylosing spondylitis (or radiographic axSpA). We learned how patients present in this stage and that despite an unacceptable delay in diagnosis (regardless of the stage), the burden of disease is high and unremitting. nr-axSpA clinical trials have been somewhat heterogeneous (with variable inclusion criteria) but have nevertheless shown considerable efficacy with tumor necrosis factor inhibitors and flare on withdrawal of therapy. Published by Elsevier Ltd.

Entities:  

Keywords:  Ankylosing spondylitis; Axial spondyloarthritis; Nonradiographic axial spondyloarthritis; Spondyloarthritis

Mesh:

Year:  2018        PMID: 30509442     DOI: 10.1016/j.berh.2018.08.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  5 in total

1.  Gait as predictor of physical function in axial spondyloarthritis: the prospective longitudinal FOLOMI (Function, Locomotion, Measurement, Inflammation) study protocol.

Authors:  Julie Soulard; Nicolas Vuillerme; Philippe Gaudin; Laurent Grange; Athan Baillet; Jean-Luc Cracowski; Robert Juvin; Jacques Vaillant
Journal:  Rheumatol Int       Date:  2019-08-07       Impact factor: 2.631

Review 2.  Targeting inflammatory pathways in axial spondyloarthritis.

Authors:  Daniel E Furst; James S Louie
Journal:  Arthritis Res Ther       Date:  2019-06-04       Impact factor: 5.156

3.  Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort.

Authors:  Regula Neuenschwander; Monika Hebeisen; Raphael Micheroli; Kristina Bürki; Pascale Exer; Karin Niedermann; Michael J Nissen; Almut Scherer; Adrian Ciurea
Journal:  Arthritis Res Ther       Date:  2020-10-09       Impact factor: 5.156

4.  Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort.

Authors:  Monika Hebeisen; Raphael Micheroli; Almut Scherer; Xenofon Baraliakos; Manouk de Hooge; Désirée van der Heijde; Robert Landewé; Kristina Bürki; Michael J Nissen; Burkhard Möller; Pascal Zufferey; Pascale Exer; Adrian Ciurea
Journal:  PLoS One       Date:  2020-03-20       Impact factor: 3.240

5.  Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study.

Authors:  Atul Deodhar; Ricardo Blanco; Eva Dokoupilová; Stephen Hall; Hideto Kameda; Alan J Kivitz; Denis Poddubnyy; Marleen van de Sande; Anna S Wiksten; Brian O Porter; Hanno B Richards; Sibylle Haemmerle; Jürgen Braun
Journal:  Arthritis Rheumatol       Date:  2020-11-24       Impact factor: 15.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.